{"id":"W2566496740","doi":"10.1158/1538-7445.am2015-5303","title":"Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"BCL6; Internal medicine; Medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Oncology; Immunohistochemistry; Lymphoma; Clinical trial; Immunology; B cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002512701,0.001102701,0.002055051,0.0003647648,0.0003613847,0.0008124359,0.0008944678,0.001037252,0.003050077],"category_scores_gemma":[0.001187667,0.0005005436,0.001256501,0.0003213602,0.001005718,0.0006178957,0.0003693008,0.002314994,0.0007507796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006964301,"about_ca_system_score_gemma":0.0009034377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007910097,"about_ca_topic_score_gemma":0.002245443,"domain_scores_codex":[0.9992886,0.0004281226,0.00004100888,0.0001067133,0.00005425518,0.00008139853],"domain_scores_gemma":[0.9990484,0.0002600838,0.0001856006,0.0001310239,0.00007595901,0.000298888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8894582,0.02836987,0.004134741,0.0004360008,0.00124785,0.0001632748,0.0001614285,0.0007005937,0.0402684,0.00009654027,0.001161117,0.03380199],"study_design_scores_gemma":[0.5014632,0.4722593,0.01703109,0.00002714701,0.001197833,0.0002543584,0.00005762059,0.0004833634,0.005287328,0.0001056503,0.001805205,0.00002791467],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948861,0.001748669,0.0003344815,0.0001823671,0.00006534572,0.0008771807,0.000935336,0.00004622164,0.0009242926],"genre_scores_gemma":[0.9911437,0.001202502,0.001306792,0.0004903492,0.0001875681,0.001015506,0.002821524,0.00003177476,0.001800445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003050077,"threshold_uncertainty_score":0.01328862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05482272988736953,"score_gpt":0.3757569179760937,"score_spread":0.3209341880887241,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}